Bradford Crutchfield, Chief Commercial Officer at 10x Genomics, Inc. (TXG), sold 29,400 shares at $190.31 ($5.5M) on 2021-04-12, disclosed to the SEC on 2021-04-13.
Open-market sale of $5.5M TXG by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $181.10 | 907 | $164K | 3.0% |
| 2 | $181.10 | 907 | $164K | 3.0% |
| 3 | $181.84 | 2,642 | $480K | 8.8% |
| 4 | $181.84 | 2,642 | $480K | 8.8% |
| 5 | $182.75 | 1,302 | $238K | 4.4% |
| 6 | $182.75 | 1,302 |
| $238K |
| 4.4% |
| 7 | $184.32 | 600 | $111K | 2.0% |
| 8 | $185.14 | 1,500 | $278K | 5.1% |
| 9 | $186.31 | 2,855 | $532K | 9.7% |
| 10 | $186.31 | 2,855 | $532K | 9.7% |
| 11 | $187.10 | 1,996 | $373K | 6.8% |
| 12 | $187.10 | 1,996 | $373K | 6.8% |
| 13 | $188.36 | 2,398 | $452K | 8.3% |
| 14 | $188.36 | 2,398 | $452K | 8.3% |
| 15 | $189.34 | 1,400 | $265K | 4.9% |
| 16 | $190.31 | 1,100 | $209K | 3.8% |
| 17 | $192.17 | 300 | $58K | 1.1% |
| 18 | $192.17 | 300 | $58K | 1.1% |
| Total | $185.62 avg | 29,400 | $5.5M | 100% |
| Filing → |
| TXG | SELL | 2022-02-24 | $23K | — | Filing → |
| TXG | SELL | 2022-02-17 | $1.6M | — | Filing → |
| TXG | SELL | 2022-01-14 | $3.5M | — | Filing → |